Vivo Capital

Vivo Capital

ICO Ended
17,107 Views
Future of Healthcare Innovation. At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees. Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China.

At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China.

At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

6.8
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

7
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 01 Oct 2018 - 15 Oct 2018
ICO Time: 16 Oct 2018 - 31 Dec 2018
Country: USA
Token info
Ticker: VCT
Platform: Ethereum
Token Type: ERC20
Financial
ICO Price: 0.0042 USD
Accepting: ETH
Soft cap: 120,000,000 USD
Hard cap: 280,000,000 USD
Q1 2018
<p>• Generating the idea.<br><br><br /> • Evaluating the market and development potential.<br><br><br /> • Market Research.</p>
Q2 2018
<p>• Launching the development.<br><br><br /> • Expanding the team.<br><br><br /> • Developing the company's legal structure.</p>
Q3 2018
<p>• Preparing for the ICO.<br><br><br /> • Whitepaper<br><br><br /> • Landing page<br><br><br /> • Performing Private Sale<br><br><br /> • Bounty & AirDrop</p>
Q4 2018
<p>• Performing the Pre-sale.<br><br><br /> • Performing ICO Main sale.<br><br><br /> • Bounty & AirDrop Distribution.</p>
Q1 2019
<p>• Exchange Listing Process starts.<br><br><br /> • Mobile application testing<br><br><br /> • Establishing Representative Office</p>
Q2 2019
<p>• Launch the Platform in Full mode<br><br><br /> • Mobile application release</p>
Q3 2019
<p>• Marketing<br><br><br /> • Licensing and entering the Asian market.</p>
Q4 2019
<p>• Obtaining the payment licenses.<br><br><br /> • Completion of developing the platform core.</p>
Lawrence Wang
Managing Director
Participates in a number of projects
Michael Chang
Managing Director
Participates in a number of projects
Jack Bech Nielsen
Managing Director
Participates in a number of projects
Gaurav Aggarwal
Managing Director
Participates in a number of projects
Frank Kung
Managing Partner
Participates in a number of projects
Albert Cha
Managing Partner
Participates in a number of projects
Shan Fu
Managing Partner
Participates in a number of projects
Chen Yu
Managing Partner
Participates in a number of projects
Derek Yang
Finance Director
Participates in a number of projects
Peiyi Zhao
Head of Legal
Participates in a number of projects
Albert Chang
Managing Partner
Participates in a number of projects
Edgar G. Engleman
Managing Partner
Participates in a number of projects
Mahendra G. Shah
Managing Director
Participates in a number of projects
Hwachie Lee
Managing Director
Participates in a number of projects
Jo Shen
Venture Partner
Participates in a number of projects
Yuh-geng Tsay
Venture Partner
Participates in a number of projects
Tracy Wu
General Director
Participates in a number of projects
Joseph Siletto
Managing Director
Participates in a number of projects
Daisy Xu
General Director
Participates in a number of projects
Nathan Dau
Associate
Participates in a number of projects
Eric Trac
Associate
Participates in a number of projects
Tiantian Zhu
Analyst
Participates in a number of projects
Ethan Zhao
Associate
Participates in a number of projects
Tierney Y. Li
Analyst
Participates in a number of projects
Andrew D. Goldberg
Principal
Participates in a number of projects
Vinayak Nikam
Associate
Participates in a number of projects
Adrianne Chang
Consultant
Participates in a number of projects
Dan Dan Dong
Principal
Participates in a number of projects
Qi Zhu
Principal
Participates in a number of projects
Nina Feng
Principal
Participates in a number of projects
Kevin Dai
Principal
Participates in a number of projects
David Liu
Principal
Participates in a number of projects
Daniel Qin
Associate
Participates in a number of projects
Lingfei Zhao
Analyst
Participates in a number of projects
Sue Shao
Associate
Participates in a number of projects
Yixuan Li
Analyst
Participates in a number of projects
Waika Cheng
Analyst
Participates in a number of projects
Aaron Royston
Senior Associate
Participates in a number of projects
Ronghuan Lin
Advisor
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Zortrax
Join the world's first ICO from a global 3D printers manufacturer. Be part of a groundbreaking opportunity to participate directly into the rapidly growing 3D printing industry. Zortrax, a producer of 3D printers and post-processing devices, introduces ZRXT tokens - bridging the crypto world with real-world technology. Zortrax Token (ZRXT) is a utility token that connects the innovative 3D printing ecosystem of Zortrax with the decentralized economy. It provides both investors and customers with real, on-chain benefits — from profit exposure via buybacks to valuable product discounts. Problem/Solution: Traditional equity and reward systems limit flexibility and exclude global retail participants. Zortrax Token introduces a hybrid model: token-based buybacks as a form of profit sharing, and utility-based discounts to reward brand loyalty and long-term engagement. Features: Profit Sharing via Buybacks: Zortrax uses a portion of its quarterly operational profits to buy back Zortrax Tokens from Uniswap v4, directly supporting token demand and price. Product Discounts Through Token Utility: - Lock-to-Discount: Users can lock Zortrax Tokens in a smart contract to receive up to 40% discount on eligible products. The amount and duration of the lock determine the discount tier. - One-Time Vouchers: Users can purchase discount vouchers (up to 40%) using tokens, without locking. This enables immediate utility and flexibility. DEX Liquidity: Tokens are freely tradable on Uniswap v4, allowing decentralized global access and real-time market pricing.
Upcoming
tokenforge
Tokenforge is a Germany-based infrastructure provider for the compliant tokenization of Real-World Assets (RWA). Since 2021, it has launched over 30 TokenSuite instances across five EU jurisdictions, fully aligned with MiCAR, eWpG, MiFID II, and national frameworks. The core product, TokenSuite, is API-first and modular, integrating KYC/KYB, e-signatures, custody, payments, and other regulated third-party services. Built under BaFin oversight, tokenforge integrates blockchain technology with traditional financial infrastructure. TokenSuite includes regulated services such as KYC, custody, payments, and registrar functions, ensuring compliance across different jurisdictions. The infrastructure will be expanded with EchoLayer, a decentralized network layer that enables cross-platform asset interaction, affiliate programs, and shared market access. Complementing this, IRIS is an AI-powered insights engine in development, designed to provide advanced analytics and decision support for asset structuring, placement, and lifecycle management within the ecosystem. At the core of tokenforge’s infrastructure is $TKFG, the native utility token. It enables issuers to access a 20% discount on service fees through staking and unlocks further benefits as the ecosystem evolves. tokenforge’s infrastructure is designed for institutional-grade scalability and positions itself as a foundational layer for the regulated digital asset industry in Europe.
Upcoming
LERN360
LERN360 is a blockchain-powered, AI-enhanced decentralized learning platform that offers multilingual, skill-based education and incentivizes learners and educators with tokenized rewards. The platform transforms global education through verifiable and accredited micro-credentials, smart learning, and learn-to-earn models.
Active
OYOFI Finance
The Platform is one stop solution for integrated Crypto DeFi Ecosystem Viz–A-Viz staking, Swapping, Tokenisation of Real World Assets and use of crypto assets in real world through OYOFI debit and credit card.
Active
FundingMeme
FundingMeme ($FM) is the World’s First Decentralized MemeCoin Prop Firm on BSC.
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.